{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04257500",
            "orgStudyIdInfo": {
                "id": "834422"
            },
            "organization": {
                "fullName": "University of Pennsylvania",
                "class": "OTHER"
            },
            "briefTitle": "Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS",
            "officialTitle": "Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS",
            "acronym": "RING-PCOS",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "does-vaginal-delivery-of-combined-hormonal-contraception-affect-the-risk-of-metabolic-syndrome-in-overweight-obese-women-with-pcos"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-06-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-01-31",
            "studyFirstSubmitQcDate": "2020-02-05",
            "studyFirstPostDateStruct": {
                "date": "2020-02-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Andrea Roe, MD, MPH",
                "investigatorTitle": "Assistant Professor of Obstetrics and Gynecology",
                "investigatorAffiliation": "University of Pennsylvania"
            },
            "leadSponsor": {
                "name": "Andrea Roe, MD, MPH",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "A prospective study to determine the metabolic effects of the contraceptive vaginal ring among overweight and obese women with polycystic ovary syndrome (PCOS). We will recruit a total of 40 participants and study use of the vaginal ring over a 4-month period."
        },
        "conditionsModule": {
            "conditions": [
                "Polycystic Ovary Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Contraceptive Ring",
                    "type": "EXPERIMENTAL",
                    "description": "Etonogestrel/ethinyl estradiol vaginal ring (NuvaRing), which releases 120 mcg of etonogestrel and 15 mcg of ethinyl estradiol daily.",
                    "interventionNames": [
                        "Drug: Etonogestrel/ethinyl estradiol vaginal ring"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Etonogestrel/ethinyl estradiol vaginal ring",
                    "description": "16 weeks of continuous use of contraceptive vaginal ring",
                    "armGroupLabels": [
                        "Contraceptive Ring"
                    ],
                    "otherNames": [
                        "NuvaRing"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Metabolic Syndrome",
                    "description": "Metabolic Syndrome defined according to the updated Adult Treatment Panel III as 3 or more of the following criteria: blood pressure \u2265130/85 mm Hg, waist circumference \\>35 inches, fasting glucose \u2265110 mg/dL, TG \u2265150 mg/dL, HDL-C \\<50 mg/dL.",
                    "timeFrame": "4 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in low-density lipoprotein (LDL) measure",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in high-density lipoprotein (HDL) measure",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in triglycerides measure",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in apolipoprotein A",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in apolipoprotein B",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in advanced lipid testing measure",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in cholesterol efflux capacity",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in fasting insulin level",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in fasting 2 hour oral Glucose Tolerance Test result",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in Testosterone",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in Ferriman-Gallwey Hirsutism score",
                    "description": "A lower score indicates less hirsutism. The F-G scoring system has a minimum value of 0, and a maximum value of 36.",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Body Mass Index",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in scoring on the Center for Epidemiologic Studies Depression Scale",
                    "description": "The range of values is zero to 60, with the higher scores indicating the presence of more depressive symptoms.",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in scoring on the State-Trait Anxiety Inventory",
                    "description": "The State-Trait Anxiety Inventory measures both state and trait anxiety, the scores range from 20 to 80, with higher scores correlating with greater anxiety.",
                    "timeFrame": "4 months"
                },
                {
                    "measure": "Change in scoring on Polycystic Ovary Syndrome Quality of Life Questionnaire",
                    "description": "Worse quality of life is associated with a lower score on the questionnaire, with a range score from 30 to 210.",
                    "timeFrame": "4 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of PCOS according to Rotterdam criteria, with at least 2 of 3 of the following criteria: oligomenorrhea (\u22648 periods per year), clinical or biochemical hyperandrogenism, and polycystic ovaries on ultrasound\n* Body mass index \u226525 and \u226445 kg/m2\n* In good general health according to the investigators' discretion\n* Willing to avoid pregnancy for the duration of the study\n\nExclusion Criteria:\n\n* Current pregnancy or desire for pregnancy during course of study\n* Current breastfeeding\n* Second-trimester pregnancy within four weeks prior to initiation of NuvaRing or third-trimester pregnancy within 6 months prior to initiation of NuvaRing\n* Use of hormonal contraception within four weeks prior to initiation of NuvaRing\n* Diagnosis of metabolic syndrome. Metabolic syndrome will be defined according to the updated Adult Treatment Panel III as 3 or more of the following criteria: blood pressure \u2265130/85 mm Hg, waist circumference \\>35 inches, fasting glucose \u2265110 mg/dL, TG \u2265150 mg/dL, HDL-C \\<50 mg/dL.\n* Contraindications to NuvaRing use:\n\n  * Age \u2265 35 plus tobacco use\n  * Current or past deep vein thrombosis or pulmonary embolism\n  * Cerebrovascular disease\n  * Coronary artery disease\n  * Thrombogenic valvular or rhythm diseases of the heart (such as subacute bacterial endocarditis with valvular disease or atrial fibrillation)\n  * Inherited or acquired coagulopathy\n  * Headaches with focal neurological symptoms or migraine headaches with aura\n  * Age \u2265 35 plus any migraine headaches\n  * Liver tumors, benign or malignant\n  * Undiagnosed abnormal uterine bleeding\n  * Current or past breast cancer or other estrogen- or progestin-sensitive cancer\n  * Hypersensitivity to any of the components of NuvaRing\n  * Use of hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir\n* Medical comorbidities:\n\n  * 21-hydroxylase deficiency, congenital adrenal hyperplasia\n  * Untreated thyroid disease\n  * Untreated hyperprolactinemia\n  * Type 1 or 2 diabetes mellitus\n  * Uncontrolled liver disease\n  * Uncontrolled renal disease\n  * Current alcohol abuse\n  * Hypertension \u2265 140 mm Hg average systolic or \u2265 90 mm Hg average diastolic in women using anti-hypertensive medication\n  * Hypertension \u2265 150 mm Hg average systolic or \u2265 100 mm Hg average diastolic in women not using anti-hypertensive medication\n  * History of or current gynecologic cancer\n  * Triglycerides \\>=250 mg/dL\n  * Current use of lipid-lowering or weight loss agents\n  * Participation in any study of an investigational drug or device or biologic agent within 30 days\n  * Suspected adrenal or ovarian tumor secreting androgens\n  * Suspected Cushing's syndrome\n  * Bariatric surgery within 12 months\n  * Other medical concerns that in the judgment of the investigator may compromise safety of the participant or confound the reliability of compliance and information acquired in this study",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "maximumAge": "40 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Andrea Morley",
                    "role": "CONTACT",
                    "phone": "215-615-4202",
                    "email": "andrea.morley@pennmedicine.upenn.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Andrea Roe, MD MPH",
                    "affiliation": "University of Pennsylvania",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Ruiz",
                            "role": "CONTACT",
                            "email": "elizabeth.ruiz@pennmedicine.upenn.edu"
                        },
                        {
                            "name": "Andrea Roe, MD, MPH",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011085",
                    "term": "Polycystic Ovary Syndrome"
                },
                {
                    "id": "D000050177",
                    "term": "Overweight"
                },
                {
                    "id": "D000024821",
                    "term": "Metabolic Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000044343",
                    "term": "Overnutrition"
                },
                {
                    "id": "D000009748",
                    "term": "Nutrition Disorders"
                },
                {
                    "id": "D000001835",
                    "term": "Body Weight"
                },
                {
                    "id": "D000007333",
                    "term": "Insulin Resistance"
                },
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000010048",
                    "term": "Ovarian Cysts"
                },
                {
                    "id": "D000003560",
                    "term": "Cysts"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010049",
                    "term": "Ovarian Diseases"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M23005",
                    "name": "Metabolic Syndrome",
                    "asFound": "Metabolic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "asFound": "Overweight",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13970",
                    "name": "Polycystic Ovary Syndrome",
                    "asFound": "Polycystic Ovary Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25307",
                    "name": "Overnutrition",
                    "relevance": "LOW"
                },
                {
                    "id": "M12684",
                    "name": "Nutrition Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5114",
                    "name": "Body Weight",
                    "relevance": "LOW"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "relevance": "LOW"
                },
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M6765",
                    "name": "Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M12971",
                    "name": "Ovarian Cysts",
                    "relevance": "LOW"
                },
                {
                    "id": "M12972",
                    "name": "Ovarian Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000004997",
                    "term": "Ethinyl Estradiol"
                },
                {
                    "id": "C000044815",
                    "term": "Etonogestrel"
                },
                {
                    "id": "C000516519",
                    "term": "NuvaRing"
                },
                {
                    "id": "D000004958",
                    "term": "Estradiol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004967",
                    "term": "Estrogens"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000080066",
                    "term": "Contraceptive Agents, Hormonal"
                },
                {
                    "id": "D000003270",
                    "term": "Contraceptive Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                },
                {
                    "id": "D000003271",
                    "term": "Contraceptive Agents, Female"
                },
                {
                    "id": "D000003278",
                    "term": "Contraceptives, Oral, Hormonal"
                },
                {
                    "id": "D000003276",
                    "term": "Contraceptives, Oral"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M8145",
                    "name": "Ethinyl Estradiol",
                    "asFound": "Protection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6494",
                    "name": "Contraceptive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M266279",
                    "name": "Estradiol 17 beta-cypionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M266280",
                    "name": "Estradiol 3-benzoate",
                    "relevance": "LOW"
                },
                {
                    "id": "M8108",
                    "name": "Estradiol",
                    "asFound": "Cell lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M234941",
                    "name": "Polyestradiol phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M264186",
                    "name": "Etonogestrel",
                    "asFound": "Script",
                    "relevance": "HIGH"
                },
                {
                    "id": "M264187",
                    "name": "NuvaRing",
                    "asFound": "Zinc sulfate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8116",
                    "name": "Estrogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M2116",
                    "name": "Contraceptive Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M6495",
                    "name": "Contraceptive Agents, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M6500",
                    "name": "Contraceptives, Oral",
                    "relevance": "LOW"
                },
                {
                    "id": "M6502",
                    "name": "Contraceptives, Oral, Hormonal",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}